Incilay Sinici Lay1, Aslı Pınar2, Filiz Akbıyık2. 1. Hacettepe University Faculty of Medicine, Department of Medical Biochemistry, Turkey; Hacettepe University Hospitals, Clinical Pathology Laboratory, Ankara, Turkey. Electronic address: lincilay@gmail.com. 2. Hacettepe University Faculty of Medicine, Department of Medical Biochemistry, Turkey; Hacettepe University Hospitals, Clinical Pathology Laboratory, Ankara, Turkey.
Abstract
OBJECTIVES: Specific types of error should be identified and corrected in each laboratory to ensure quality results. The objectives of this study were: DESIGN AND METHODS: Data on rejected biological specimens in the laboratory information system from January 2013 to January 2014 were analyzed. SSRs according to the type of pre-preanalytical error and collection area were determined. RESULTS: In total, 971,780 biological specimens were received during the period and 26,070 (2.7%) specimens were rejected based on our laboratory rejection criteria. The most frequent reason for the rejection was the clotted specimen (55.8% of total rejections), followed by inadequate volume (29.3% of total rejections). Most of the clotted specimens were received from adult hospital inpatient services (54.3%), followed by pediatric hospital inpatient services (26.8%). High rates of inadequate volume were also observed in samples originating from adult and pediatric hospital inpatient services, especially in the premature, neonatal, intensive care, and oncology units. CONCLUSIONS: The SSR of clotted specimens was selected as the QI for the preanalytical phase in our laboratory. The selected QI will help to define the effects of our specific interventions and corrective actions, and thus allow monitoring of quality improvement in our hospitals.
OBJECTIVES: Specific types of error should be identified and corrected in each laboratory to ensure quality results. The objectives of this study were: DESIGN AND METHODS: Data on rejected biological specimens in the laboratory information system from January 2013 to January 2014 were analyzed. SSRs according to the type of pre-preanalytical error and collection area were determined. RESULTS: In total, 971,780 biological specimens were received during the period and 26,070 (2.7%) specimens were rejected based on our laboratory rejection criteria. The most frequent reason for the rejection was the clotted specimen (55.8% of total rejections), followed by inadequate volume (29.3% of total rejections). Most of the clotted specimens were received from adult hospital inpatient services (54.3%), followed by pediatric hospital inpatient services (26.8%). High rates of inadequate volume were also observed in samples originating from adult and pediatric hospital inpatient services, especially in the premature, neonatal, intensive care, and oncology units. CONCLUSIONS: The SSR of clotted specimens was selected as the QI for the preanalytical phase in our laboratory. The selected QI will help to define the effects of our specific interventions and corrective actions, and thus allow monitoring of quality improvement in our hospitals.
Authors: Euan J McCaughey; Elia Vecellio; Rebecca Lake; Ling Li; Leslie Burnett; Douglas Chesher; Stephen Braye; Mark Mackay; Stephanie Gay; Tony C Badrick; Johanna I Westbrook; Andrew Georgiou Journal: Clin Biochem Rev Date: 2016-12
Authors: Soha A Tashkandi; Ali Alenezi; Ismail Bakhsh; Abdullah AlJuryyan; Zahir H AlShehry; Saeed AlRashdi; Maryjane Guzman; Marvin Pono; Franklin Lim; April Rose Tabudlong; Lamees Elwan; Musa Fagih; Ahmad Aboabat Journal: BMC Fam Pract Date: 2021-05-27 Impact factor: 2.497